399 — Starcoin Share News
0.000.00%
Last trade - 00:00IndustrialsHighly SpeculativeMicro Cap
Brief: Innovative Pharmaceutical Biotech Says Conditionally Agreed To Issue Convertible Bonds
Brief: Innovative Pharmaceutical Biotech Says Issue Of New Shares
Brief: Innovative Pharmaceutical Biotech Says Cheng Tak Yiu Appointed As An Executive Director
Brief: Innovative Pharmaceutical Biotech Says FY Loss Attributable HK$245.7 Mln
Brief: Innovative Pharmaceutical Biotech Says Possible Capital Injection Into Beijing Allwegene Technology
Brief: Innovative Pharmaceutical Biotech Says HY Loss Attributable HK$115.7 Mln
Brief: Innovative Pharmaceutical Biotech Sees Loss Attributed For HY Between Hk$110 Mln & Hk$130 Mln
Brief: Innovative Pharmaceutical Biotech Posts HY Profit Attributable Of HK$125.1 Million
Brief: Innovative Pharmaceutical Biotech Sees Profit Attributed For Six Months In Range Between HK$100 Mln & HK$200 Mln
Brief: Innovative Pharmaceutical Biotech FY Loss Attributable Hk$204.9 Million
Brief: Innovative Pharmaceutical Biotech Posts HY Loss Attributable Hk$93.4 Million
Brief: Innovative Pharmaceutical Biotech Says Huang He Retired As Executive Director
Brief: Innovative Pharmaceutical Biotech Posts HY Loss Attributable HK$110.5 MLN
Brief: Innovative Pharmaceutical Biotech Agreed To Sell Stake In Extrawell Pharmaceutical
Brief: Innovative Pharmaceutical Biotech Posts FY Revenue HK$18.6 Mln
Brief: Innovative Pharmaceutical Biotech Says Co To Sell Shares In Extrawell Pharmaceutical
Brief: Innovative Pharmaceutical Biotech Seeks Trading Halt
Brief: Innovative Pharmaceutical Biotech Posts HY Loss Attributable Of HK$171.3 Mln
Brief: Innovative Pharmaceutical Biotech Posts FY Revenue HK$15.8 MLN